-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Wa9bl0lKW/qr9YW33PQXh/NbS4PZdwHmjTx9wtSygWwCZSws7XmX3iEcuaO7FB/0 cTbR+pqq0XqJPMOit9ZhrA== 0001088020-01-500023.txt : 20010614 0001088020-01-500023.hdr.sgml : 20010614 ACCESSION NUMBER: 0001088020-01-500023 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20010601 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20010613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES INC CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-13070 FILM NUMBER: 1660242 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 100 CITY: PRINCETON STATE: NJ ZIP: 08540 8-K 1 body_060101.htm DATED JUNE 1, 2001 Derma Sciences, Inc. Form 8-K dated June 1, 2001



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





FORM 8-K


CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934




Date of Report (Date of earliest event reported): June 1, 2001



Derma Sciences, Inc.
(Exact name of registrant as specified in its charter)


Pennsylvania 1-31070 23-2328753
(State or other jurisdiction (Commission (IRS employer
of incorporation) File Number) identification number)




214 Carnegie Center, Suite 100
Princeton, NJ 08540
(609) 514-4744
(Address including zip code and telephone
number, of principal executive offices)




Item 5. Other Events

        Effective June 1, 2001, the Registrant executed one-year employment agreements with its president and chief executive officer, Edward J. Quilty, and its vice president and chief financial officer, John E. Yetter, CPA. Each agreement provides for payment of severance compensation in the amount of one year’s base salary upon the Registrant’s failure to renew the agreement for successive one-year terms. In addition, upon a change in control of the Registrant, each executive may, within six months of the change in control, tender his resignation and receive one year’s severance compensation.

        The agreements provide for base compensation in the amounts of $200,000 and $160,500 per year for Edward J. Quilty and John E. Yetter, CPA, respectively. The agreements further provide for the payment of incentive/bonus compensation in the discretion of the Registrant’s board of directors. The agreements for Messrs. Quilty and Yetter are incorporated herein by reference and attached hereto as Exhibits 10.01 and 10.02, respectively.

Item 7. Financial Statements and Exhibits

           (a)    Not applicable
           (b)    Not applicable
           (c)    Exhibits:

                    10.01 – Employment Agreement between the Registrant and Edward J. Quilty dated June 1, 2001.
                    10.02 – Employment Agreement between the Registrant and John E. Yetter, CPA dated June 1, 2001.





2


        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


    DERMA SCIENCES, INC.
     
     
     
Date: June 11, 2001   By: /s/ John E. Yetter     
      John E. Yetter, CPA
      Vice President and Chief Financial Officer





3


EX-10.01 2 ex10-01.txt QUILTY AGREEMENT AGREEMENT THIS AGREEMENT, made as of the 1st day of June, 2001 by and between Derma Sciences, Inc., a business corporation organized under the laws of the Commonwealth of Pennsylvania ("Employer"), and Edward J. Quilty ("Employee"). WHEREAS, Employee is currently employed by Employer as its President, Chairman and Chief Executive Officer, and WHEREAS, the parties desire to memorialize the terms and conditions of Employee's employment by Employer, NOW, THEREFORE, the parties hereto, in consideration of the mutual promises and covenants herein contained, hereby agree as follows: 1. EMPLOYMENT. Employer hereby employs Employee, and Employee agrees to be employed by Employer, as Employer's President, Chairman and Chief Executive Officer upon the terms and conditions hereinbelow set forth. 2. TIME AND EFFORTS. Employee will devote substantially all of his business time and efforts to his duties hereunder. 3. COMPENSATION. During the Term hereof Employer shall pay compensation to Employee as follows: (a) Base compensation at the rate of Two Hundred Thousand Dollars ($200,000) per year; (b) Bonus, stock options and/or such other incentive compensation as may be determined by Employer's board of directors upon recommendation of its compensation committee. 1 Reviews by the compensation committee of Employee's base compensation and incentive compensation shall be undertaken not less often than annually. The principal criteria utilized by the compensation committee in the conduct of its reviews shall be the extent to which Employer attains its performance objectives and the extent of Employee's contributions thereto. 4. TERM. This Agreement shall be effective as of June 1, 2001 and shall expire on May 31, 2002 unless renewed or extended by mutual agreement of the parties hereto. 5. SEVERANCE. Upon the failure by Employer, on or prior to each anniversary hereof, to extend to Employee its offer to renew this Agreement for the succeeding twelve month period, and provided only that Employer's failure to renew this Agreement is "without cause," Employer shall pay to Employee severance compensation in the amount of one year's base compensation at the rate most recently in effect pursuant to paragraph 3(a) hereof. 6. CHANGE IN CONTROL. Within six months of the occurrence of a "change in control" of Employer (defined below), Employee may, but shall have no obligation to, tender his resignation from Employer and receive severance compensation as provided in paragraph 5 above to the same extent as if Employer failed to renew this Agreement "without cause." For purposes of this paragraph, a "change in control" shall mean a change in ownership of stock possessing greater than fifty percent (50%) of the total combined voting power of all classes of stock entitled to vote of Employer. 7. OPTION EXERCISE EXTENSION. In the event either that Employer fails to renew this Agreement "without cause" or Employee tenders his resignation upon a "change in control," then the period to exercise any option to purchase the securities of Employer of 2 which Employee may be possessed shall be extended to the expiration thereof as set forth in the option instrument. IN WITNESS WHEREOF, this Agreement has been executed by Employee and Employer by a member of its board of directors and its compensation committee thereunto duly authorized. EMPLOYER: DERMA SCIENCES, INC. By: ------------------------------------------- Stephen T. Wills, CPA, MST Chairman - Compensation Committee EMPLOYEE: ---------------------------------------------- Edward J. Quilty 3 EX-10.02 3 ex10-02.txt YETTER AGREEMENT AGREEMENT THIS AGREEMENT, made as of the 1st day of June, 2001 by and between Derma Sciences, Inc., a business corporation organized under the laws of the Commonwealth of Pennsylvania ("Employer"), and John E. Yetter, CPA ("Employee"). WHEREAS, Employee is currently employed by Employer as its Vice President and Chief Financial Officer, and WHEREAS, the parties desire to memorialize the terms and conditions of Employee's employment by Employer, NOW, THEREFORE, the parties hereto, in consideration of the mutual promises and covenants herein contained, hereby agree as follows: 1. EMPLOYMENT. Employer hereby employs Employee, and Employee agrees to be employed by Employer, as Employer's Vice President and Chief Financial Officer upon the terms and conditions hereinbelow set forth. 2. TIME AND EFFORTS. Employee will devote substantially all of his business time and efforts to his duties hereunder. 3. COMPENSATION. During the Term hereof Employer shall pay compensation to Employee as follows: (a) Base compensation at the rate of One Hundred Sixty Thousand Five Hundred Dollars ($160,500) per year; (b) Bonus, stock options and/or such other incentive compensation as may be determined by Employer's board of directors upon recommendation of its compensation committee. 1 Reviews by the compensation committee of Employee's base compensation and incentive compensation shall be undertaken not less often than annually. The principal criteria utilized by the compensation committee in the conduct of its reviews shall be the extent to which Employer attains its performance objectives and the extent of Employee's contributions thereto. 4. TERM. This Agreement shall be effective as of June 1, 2001 and shall expire on May 31, 2002 unless renewed or extended by mutual agreement of the parties hereto. 5. SEVERANCE. Upon the failure by Employer, on or prior to each anniversary hereof, to extend to Employee its offer to renew this Agreement for the succeeding twelve month period, and provided only that Employer's failure to renew this Agreement is "without cause," Employer shall pay to Employee severance compensation in the amount of one year's base compensation at the rate most recently in effect pursuant to paragraph 3(a) hereof. 6. CHANGE IN CONTROL. Within six months of the occurrence of a "change in control" of Employer (defined below), Employee may, but shall have no obligation to, tender his resignation from Employer and receive severance compensation as provided in paragraph 5 above to the same extent as if Employer failed to renew this Agreement "without cause." For purposes of this paragraph, a "change in control" shall mean a change in ownership of stock possessing greater than fifty percent (50%) of the total combined voting power of all classes of stock entitled to vote of Employer. 7. OPTION EXERCISE EXTENSION. In the event either that Employer fails to renew this Agreement "without cause" or Employee tenders his resignation upon a "change in control," then the period to exercise any option to purchase the securities of Employer of 2 which Employee may be possessed shall be extended to the expiration thereof as set forth in the option instrument. IN WITNESS WHEREOF, this Agreement has been executed by Employee and Employer by a member of its board of directors and its compensation committee thereunto duly authorized. EMPLOYER: DERMA SCIENCES, INC. By: ---------------------------------------- Edward J. Quilty President and Chief Executive Officer EMPLOYEE: -------------------------------------------- John E. Yetter, CPA 3
-----END PRIVACY-ENHANCED MESSAGE-----